摘要
本文对早期接受β受体阻滞剂治疗的急性前壁心肌梗塞患者进行了分析。结果:治疗组(24例)较非治疗组(80例)室性心律失常的发生率显著降低(P<0.005);早期病死率也显著降低(P<0.05);并且梗塞后心绞痛的发生率降低(P<0.05)。表明早期应用β受体阻滞剂可有效地降低急性前壁心肌梗塞的室性心律失常发生率;减少并发症的发生,降低病死率。
The analysis was made in patients with acute myocardial infarction (AMI) by early β-a- drenocepter blooking drugs treatment. The results showed that the incidence of ventricle arrhyth- mia was significantly lower in 24 cases of treatment group than in 80 cases of non-treatment (P< 0. 005), the early mortality remarkbly decreased (P<0.05), and the incidence of angina pectoris after myocardial infarction also delined (P<0. 05). In cinclusion, the early application of β-a- drenocepter blooking drugs may effectively decreasee vantrical arrhythmia after AMI, with de- clined incidence of compli-cation and mortality.
关键词
Β受体阻滞剂
心肌梗塞
预后
β-adrenocepter blooking drugs
myocardial infarction
prognosis
